Current Assets 更改
Gilead Sciences USD 16.45B 474M 2023-12
RedHill Biopharma USD 27.05M 19.47M 2023-06
Supernus Pharmaceuticals USD 493.11M 43.75M 2023-12



Intra Cellular Therapies 流动资产 - 当前值,历史数据,预测,统计,图表和经济日历 - May 2024.